Industry News
-
Neurogene AAV Gene Therapy NGN-401 Shows Multidomain Skill Gains in Rett Syndrome Trial
Nov 12 2025 -
FDA Unveils New Regulatory Pathway to Streamline Bespoke Gene Therapies and Personalized Medicine
Nov 12 2025 -
Novel AAV Gene Therapy Reverses Heart Failure in Preclinical Model, Targeting Contractile and Electrical Deficits
Nov 11 2025 -
Metagenomi’s Dual-Component AAV Gene Editing Therapy MGX-001 Demonstrates Curative FVIII Activity in Non-Human Primates
Nov 11 2025 -
Dyno Therapeutics Unveils AI-Engineered AAV Capsid Dyno-bn8 for Muscle Gene Therapy
Nov 11 2025 -
Medley Doses First Cohort in AAV Gene Therapy Trial for Heart Regeneration
Nov 11 2025 -
Lilly Secures AAV-AIPL1 Gene Therapy Rights from MeiraGTx in $475M Deal
Nov 10 2025 -
Akeso Doses First Patient in Phase 1 Trial of Personalized mRNA Vaccine AK154 for Pancreatic Cancer
Nov 10 2025 -
Leucid Bio Announces Encouraging Proof-of-Concept Data for Novel CAR-T Therapy LEU011 in Solid Tumours
Nov 10 2025